ArticleLancet (London, England)2020
Did the hesitancy in declaring COVID-19 a pandemic reflect a need to redefine the term?
Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- To tier or not to tier: the institutionalization of the World Health Organization's power to determine pandemic emergency in the amended International Health Regulations (2005).Global health research and policy · 2025Article
- The effects of COVID-19 on agriculture supply chain, food security, and environment: a review.PeerJ · 2024Review
- Climate and COVID-19 transmission: a cross-sectional study in Africa.Scientific reports · 2023Article
- Comparison of COVID-19 vaccine policies and their effectiveness in Korea, Japan, and Singapore.International journal for equity in health · 2023Article
- Impact assessment of COVID-19 global pandemic on water, environment, and humans.Environmental advances · 2023Article
- Tracking collective emotions in 16 countries during COVID-19: a novel methodology for identifying major emotional events using Twitter.Frontiers in psychology · 2023Article
- COVID-19 2022 update: transition of the pandemic to the endemic phase.Human genomics · 2022Review
- A multi-regional, hierarchical-tier mathematical model of the spread and control of COVID-19 epidemics from epicentre to adjacent regions.Transboundary and emerging diseases · 2022Article
- COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy.Human genomics · 2021Review
- SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients.Cancers · 2020Review
- Linking key intervention timings to rapid declining effective reproduction number to quantify lessons against COVID-19.Frontiers of medicine · 2020Article
- Pandemicity, COVID-19 and the limits of public health 'science'.BMJ global health · 2020Article
- Generation of Chicken IgY against SARS-COV-2 Spike Protein and Epitope Mapping.Journal of immunology research · 2020Article
- The Inhibitory Effect of Curcumin on Virus-Induced Cytokine Storm and Its Potential Use in the Associated Severe Pneumonia.Frontiers in cell and developmental biology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.